Positive Data Supporting A New Biomarker Predicting The Efficacy Of Current Hormone T

[News]

Invivis Pharmaceuticals, Inc., a clinical stage biopharmaceutical private company focused on the development of oncology therapeutics, have announced new, positive data supporting the development of its biomarkers to be presented at the American Society of Clinical Oncology (ASCO) 2013 Annual Meeting, May 31-June 4, 2013 in Chicago, Illinois...

More... (http://www.medicalnewstoday.com/releases/261114.php)